Clinical updates, including trial initiations, enrollment status and data readouts and publications: Eli Lilly, Eirgenix, Hyundai, Immix, Immunogen, Karyopharm, Pharmaessentia, Transcenta, Vicore.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle, Kalos, Neurosense, Photocure, Smartlens, Widex.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Belief Biomed, Bionomics, Daewoong, I-Mab, Inmagene, Junshi, Lianbio, Olix, Otsuka, Ovid, SAB, Sunovion, Takeda.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Almirall, CG, Eli Lilly, Horizon, J&J, Lipella, Pliant, Urogen, Zambon.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D Molecular, Actinium, Avidity, Inmagene, Kiora, Nanoscope, Olix, Ovid, Takeda, Tempest.